MorphoSys Inc. (MOR) stock fell during pre-market trading. Here’s the recent update
MorphoSys Inc. (NASDAQ: MOR) stock declined by 1.74% at last close while the MOR stock price plunged by 6.62% in the pre-market trading session. MorphoSys is a commercial-stage pharmaceutical business focused on the research, development, and commercialization of novel treatments for cancer and autoimmune disorders patients. >> 7 Top Picks for the Post-Pandemic Economy << […]
